Wellous
HomeMeRewardsReviewsProfilePolicy NoticeTerms & Conditions

I have bought MoveOn the first time and after taking the first box, my knee is not so pain. While taking half way on the 2nd box my knee is completely no more pain. So balance half i gave them to my bro who also have knee pain and after he took for 4,5 days, he told me his knee no more pain. So i bought my 2nd purchase with LiveOn for my bro and he is happy with this products. And for myself, i will buy again if there is promotion as i found it is quite expensive if no offer

I have bought MoveOn the first time and after taking the first box, my knee is not so pain. While taking half way on the 2nd box my knee is completely no more pain. So balance half i gave them to my bro who also have knee pain and after he took for 4,5 days, he told me his knee no more pain. So i bought my 2nd purchase with LiveOn for my bro and he is happy with this products. And for myself, i will buy again if there is promotion as i found it is quite expensive if no offer

Suggested For You

Brand new year, brand new healthier you! 🎉

Brand new year, brand new healthier you! 🎉

This coming 2025, let's embark on a journey of wellness and positivity together. 🌟

With Wellous by your side, let's make wellness feel joyous every single day.

Did You Know?🤔 Nearly 40% of Malaysian adults have non-alcoholic fatty liver disease (NAFLD), the most common liver issue in the country.

Did You Know?🤔 Nearly 40% of Malaysian adults have non-alcoholic fatty liver disease (NAFLD), the most common liver issue in the country.

Our latest newsletter dives deep into understanding liver health! You'll explore a range of common liver conditions, the ways to prevent viral hepatitis and fatty liver, and our featured products - LIVETAL & HOMEGA to support your liver health. Also, don't miss out on our Digital Detox Challenge to give your mind and body a break!🧡✨

Click the link below to access the full newsletter and learn more about keeping your liver healthy!🥰

👉 https://cdn.wellous.com/membership/article/newsletter/2024/2024-q2-en.pdf